{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:10:45Z","timestamp":1782587445043,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.urolonc.2025.10.018","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T04:38:09Z","timestamp":1764650289000},"page":"122.e11-122.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Renal epithelioid angiomyolipoma: A multi-institutional, international cohort study with emphasis on clinicopathologic prognostic indicators"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5184-2799","authenticated-orcid":false,"given":"Angela","family":"Pecoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Amparore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cali\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Carbonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Distante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcuk","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Margue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Martignoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantijn H.J.","family":"Muselaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Albersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Raspollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.urolonc.2025.10.018_bib0002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PAS.0b013e31817ed7a6","article-title":"Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association","volume":"33","author":"Aydin","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.018_bib0003","first-page":"18","article-title":"Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): a single institution series","volume":"40","author":"Saoud","year":"2022","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"3","key":"10.1016\/j.urolonc.2025.10.018_bib0004","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2289","article-title":"Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma","volume":"214","author":"Pan","year":"2008","journal-title":"J Pathol"},{"issue":"10","key":"10.1016\/j.urolonc.2025.10.018_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13102441","article-title":"Cathepsin k: a novel diagnostic and predictive biomarker for renal tumors","volume":"13","author":"Cali\u00f2","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.urolonc.2025.10.018_bib0006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/kjm2.12006","article-title":"Clinicopathologic analysis of renal epithelioid angiomyolipoma: consecutively excised 23 cases","volume":"35","author":"Tsai","year":"2019","journal-title":"Kaohsiung J Med Sci"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.018_bib0007","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0b013e318206f2a9","article-title":"Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailedassessment of morphology and risk stratification","volume":"35","author":"Nese","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.urolonc.2025.10.018_bib0008","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/PAS.0b013e3181d90370","article-title":"Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy","volume":"34","author":"Brimo","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2025.10.018_bib0009","article-title":"A rare case of spontaneous rupture of epithelioid angiomyolipoma","volume":"38","author":"Benincasa","year":"2021","journal-title":"Urol Case Reports"},{"key":"10.1016\/j.urolonc.2025.10.018_bib0010","doi-asserted-by":"crossref","unstructured":"2022 Yang J. Advancements in the diagnosis and treatment of renal epithelioid angiomyolipoma: a narrative review. ;(March):925\u2013932. doi:10.1002\/kjm2.12586.","DOI":"10.1002\/kjm2.12586"},{"issue":"6","key":"10.1016\/j.urolonc.2025.10.018_bib0011","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/2001-125-0751-RA","article-title":"Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum","volume":"125","author":"Stone","year":"2001","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.urolonc.2025.10.018_bib0012","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00000478-200101000-00007","article-title":"Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers","volume":"25","author":"Zavala-Pompa","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.urolonc.2025.10.018_bib0013","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.pathol.2020.09.025","article-title":"Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney","volume":"53","author":"Cali\u00f2","year":"2021","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.urolonc.2025.10.018_bib0014","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00000478-200006000-00017","article-title":"Renal angiomyolipoma with epithelioidsarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions","volume":"24","author":"Martignoni","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"March","key":"10.1016\/j.urolonc.2025.10.018_bib0015","first-page":"1","article-title":"A four-year follow-up study of renal epithelioid angiomyolipoma: a multi-center experience and literature review","volume":"5","author":"Lei","year":"2015","journal-title":"Sci Rep"},{"issue":"17","key":"10.1016\/j.urolonc.2025.10.018_bib0016","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1158\/1078-0432.CCR-19-0288","article-title":"Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas)","volume":"25","author":"Sanfilippo","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.urolonc.2025.10.018_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.urolonc.2025.10.018_bib0018","doi-asserted-by":"crossref","unstructured":"Liapi A., Mathevet P., Herrera F.G., Hastir D., Sarivalasis A. VEGFR inhibitors for uterine metastatic perivascular epithelioid tumors (PEComa) resistant to mTOR inhibitors. A case report and review of literature. Front Oncol. 2021;11(March):1\u20137. doi:10.3389\/fonc.2021.641376","DOI":"10.3389\/fonc.2021.641376"},{"issue":"1","key":"10.1016\/j.urolonc.2025.10.018_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0415-x","article-title":"Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy","volume":"6","author":"Lattanzi","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.urolonc.2025.10.018_bib0020","doi-asserted-by":"crossref","unstructured":"McCharthy M., Nichols P.E., Vidit S. et al., Molecular and immunophenotypic correlates of metastatic epithelioid angiomyolipoma include alterations of TP53, RB1, and ATRX Arch Pathol Lab Med . 2023;147(7):817\u2013825. doi: 10.5858\/arpa.2022-0127-OA.","DOI":"10.5858\/arpa.2022-0127-OA"},{"key":"10.1016\/j.urolonc.2025.10.018_bib0021","doi-asserted-by":"crossref","unstructured":"Rammal R, Korentzelos D, Skaugen JM, Quiroga-Garza GM. Molecular Characterization of Malignant Renal Epithelioid Angiomyolipoma: A Review of Two Cases. Am J Clin Pathol. 2023;159(3):211-220. 10.1093\/ajcp\/aqac152. PMID: 36661215.","DOI":"10.1093\/ajcp\/aqac152"},{"key":"10.1016\/j.urolonc.2025.10.018_bib0022","doi-asserted-by":"crossref","unstructured":"Gagnon M.F., Schoolmeester J.K., Dasari S. et al., Molecular alterations in primary and metastatic PEComa: insights from the AACR project GENIE data set Hum Pathol. 2024:143:75\u201376. 10.1016\/j.humpath.2023.10.001.","DOI":"10.1016\/j.humpath.2023.10.001"},{"key":"10.1016\/j.urolonc.2025.10.018_bib0023","doi-asserted-by":"crossref","unstructured":"Bennet J.A., Ordulu Z., Pinto A. et al., Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions Mod Pathol. 2022;35(4):515\u2013523. doi:10.1038\/s41379-021-00855-1.","DOI":"10.1038\/s41379-021-00855-1"},{"issue":"5","key":"10.1016\/j.urolonc.2025.10.018_bib0024","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/PAS.0000000000002028","article-title":"A clinicopathologic and molecular characterization of uterine sarcomas classified as malignant PEComa","volume":"47","author":"Anderson","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.urolonc.2025.10.018_bib0025","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/PAS.0000000000002276","article-title":"PEComa with MITF overexpression: Clinicopathologic and molecular analysis of a series of 36 cases","volume":"48","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2025.10.018_fur1","doi-asserted-by":"crossref","unstructured":"Lopez-Beltran A., Scarpelli M., Montironi R., Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006;49(5):798\u2013805. doi:10.1016\/j.eururo.2005.11.035.","DOI":"10.1016\/j.eururo.2005.11.035"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:30:39Z","timestamp":1769257839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1078143925004120"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.10.018","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal epithelioid angiomyolipoma: A multi-institutional, international cohort study with emphasis on clinicopathologic prognostic indicators","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}